Further advice on the third generation synthetic cannabinoids: recommendations and addendum

Document type
Guidance note
Advisory Council on the Misuse of Drugs
Date of publication
14 January 2016
Substance Misuse
Social welfare
Material type

Download (54KB )

This note recommends further revisions to the original report on third generation synthetic cannabinoids. On the 27 November 2014 the Advisory Council on the Misuse of Drugs (ACMD) provided advice to the then Minister for Crime Prevention on third generation synthetic cannabinoids. The advice included an additional generic control drafted to address the wide range of ‘third generation’ synthetic cannabinoids then being seen. On the 25 March 2015 the ACMD published an addendum, which recommended an amendment to the generic definition.  However, since March 2015 several new synthetic cannabinoids, which are outside the scope of the proposed generic definition in the ACMD report, have appeared on the market or reported in a patent. These include ten which are available in medicinal products approved for use in the UK or elsewhere within the EU. The ACMD therefore recommends revisions to two paragraphs and two annexes in the original report.

Related to Substance Misuse

Drug misuse and dependence: UK guidelines on clinical management

Downloadable guidelines on treating people with drug misuse and drug dependence problems

Family drug and alcohol court national unit: independent evaluation: research report

The family drug and alcohol court (FDAC) offers an alternative form of care proceedings for children put at risk of significant…

Fourth addendum to ACMD’s report on synthetic cannabinoids

This addendum recommends revisions to the regulations regarding the scheduling of synthetic cannabinoids. Specifically, they…

More items related to this subject